Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX07V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 30 Oct 2001 14:16:43 -0600
Received: from corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 30 Oct 2001 14:16:43 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T56ea60e04cc0a86ee2868@corp.enron.com> for <gwhalle@exchange.enron.com>;
 Tue, 30 Oct 2001 14:16:44 -0600
Received: from pbulk01.thestreet.com ([209.67.12.144])
	by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with SMTP id f9UKGgV02938
	for <gwhalle@ect.enron.com>; Tue, 30 Oct 2001 14:16:42 -0600 (CST)
Received: (qmail 14984 invoked from network); 30 Oct 2001 17:16:56 -0000
Received: from bulk-mgr01.thestreet.com (prod@192.168.20.20)
  by pbulk01-o0.thestreet.com with QMQP; 30 Oct 2001 17:16:56 -0000
Date: 30 Oct 2001 12:16:04 -0500
Message-ID: <20011030171414.21727.bulk_mail.11040@192.168.24.17>
To: "members@realmoney.com" <prod-special@pbulk01.thestreet.com>
From: <members@realmoney.com>
Reply-To: <members@realmoney.com>
Subject: Only 2 days left to save $100!
Return-Path: bounce-special-2001_10_30_17_14_14-gwhalle=ect.enron.com@pbulk01.thestreet.com




**Register before November 1st and save $100!**
http://www.twst.com/pharmaregister/thestreet


Dear Investor,

Do you want to find out what the latest and hottest trends are 
in the pharmaceutical industry?  Get all of the information  
you need from the industry leaders at the, "Investing in 
the Pharmaceutical Industry Conference".

The Street.com and The Wall Street Transcript would like to 
personally invite you to this year's conference, which is being held on 
Thursday, December 6th.  The conference will be an all day 
event at The Princeton Club in New York City.

The event, hosted by The Wall Street Transcript and media partner
TheStreet.com, will feature top financial officials and corporate 
executives in the Pharmaceutical industry, as well as leaders from 
the academia field and government agencies.  These groups will 
engage in two dynamic roundtable discussions and will also be 
available for various one-on-one interviews, all aimed at giving you 
the specific information that you need to make smarter investments 
in the pharmaceutical industry!

-----------------------------------------------------------------
Sign up today and receive a $100 discount!
http://www.twst.com/pharmaregister/thestreet
-----------------------------------------------------------------

Here are just a few of our presenters:

Eran Broshy, PhD - CEO Ventiv Heath 
Malcolm Gefter, PhD - CEO Praecis Pharmaceuticals 
Lee Babiss - R&D Hoffmann-LaRoche 
Robert Hazlett -  Robertson Stephens 
Derek Taner - Franklin Templeton Global Healthcare Fund 
Jerry Treppel - Bank of America Securities LLC 
Faraz Naqvi - Dresdner RCM Biotechnology Fund

These prominent industry executives will give you the inside 
track on which companies are best positioning their 
drugs and brands to maintain and grow their market share.
You'll also be able to uncover the challenges that companies 
face in research and development, and also which companies have 
the most effective strategies in mergers, acquisitions and 
outsourcing.

Hear from Wall Street's best analysts and money managers 
on which companies have the drugs likely to be the next 
blockbusters that will translate their companies into 
outstanding investments!

Register now before the conference fills up!  Spaces are limited. 

Sign up before November 1st and receive $100 off the 
registration fee!

------------------------------------------------------------------
You may reserve your seats by either calling 
1-800-562-9571, or registering online at
http://www.twst.com/pharmaregister/thestreet.
------------------------------------------------------------------

Sincerely,

Andrew Pickup
Publisher, The Wall Street Transcript


------------------------------------------------------------------
Brought to you by TheStreet.com
www.thestreet.com
------------------------------------------------------------------

This email has been sent to you by TheStreet.com because 
you are a current or former subscriber (either free-trial 
or paid) to one of our web sites, http://www.thestreet.com/ or 
http://www.realmoney.com/. If you would prefer not to receive 
these types of emails from us in the future, please click here: 
http://www.thestreet.com/z/unsubscribe.jhtml?Type=M  
If you are not a current or former subscriber, and you believe 
that you have received this message in error, please forward 
this message to members@realmoney.com with "UNSUBSCRIBE" as the 
subject line, or call our customer service department at 
1-800-562-9571.

Please be assured that we respect the privacy of our 
subscribers. To view our privacy policy, please 
click here: http://www.thestreet.com/tsc/about/privacy.html

